15,366 ARK Genomic Revolution ETF $ARKG Shares Bought by Global View Capital Management LLC

Global View Capital Management LLC increased its holdings in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 59.0% during the 3rd quarter, Holdings Channel.com reports. The fund owned 41,424 shares of the company’s stock after acquiring an additional 15,366 shares during the period. ARK Genomic Revolution ETF accounts for about 0.5% of Global View Capital Management LLC’s portfolio, making the stock its 25th largest position. Global View Capital Management LLC’s holdings in ARK Genomic Revolution ETF were worth $2,246,000 as of its most recent filing with the SEC.

Several other institutional investors have also made changes to their positions in ARKG. NewEdge Advisors LLC raised its position in ARK Genomic Revolution ETF by 102.6% in the first quarter. NewEdge Advisors LLC now owns 24,092 shares of the company’s stock worth $637,000 after purchasing an additional 12,202 shares in the last quarter. Nwam LLC lifted its stake in ARK Genomic Revolution ETF by 55.3% during the second quarter. Nwam LLC now owns 31,704 shares of the company’s stock worth $1,333,000 after purchasing an additional 11,294 shares during the period. Group One Trading LLC lifted its stake in ARK Genomic Revolution ETF by 168.3% during the first quarter. Group One Trading LLC now owns 45,861 shares of the company’s stock worth $1,212,000 after purchasing an additional 28,765 shares during the period. Gimbal Financial acquired a new stake in ARK Genomic Revolution ETF during the third quarter valued at approximately $6,478,000. Finally, Moran Wealth Management LLC boosted its holdings in ARK Genomic Revolution ETF by 79.6% during the first quarter. Moran Wealth Management LLC now owns 49,204 shares of the company’s stock valued at $1,300,000 after purchasing an additional 21,811 shares in the last quarter.

ARK Genomic Revolution ETF Stock Down 6.7%

BATS ARKG opened at $51.40 on Friday. ARK Genomic Revolution ETF has a 1-year low of $24.60 and a 1-year high of $58.83. The stock’s 50 day moving average is $49.92 and its two-hundred day moving average is $37.37.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.